Abstract
The European Paediatric Mycology Network (EPMyN) was launched in 2014 to create a European platform for research and education in the field of paediatric mycology. The EPMyN aims to address the lack of paediatric specific evidence and knowledge needed to (1) improve the management and outcome of invasive fungal infections in children and neonates and to (2) enhance and develop paediatric antifungal stewardship programmes.
Highlights
The European Paediatric Mycology Network (EPMyN) was launched in 2014 to create a European platform for research and education in the field of paediatric mycology
Its mission is to increase the knowledge of the epidemiology and pathogenesis and to improve the management of invasive fungal infections in neonates and children
The need for EPMyNcan be found in the unique epidemiology of invasive fungal infections in neonates and children, differences in pharmacokinetics of antifungal agents and usefulness of fungal diagnostic measures compared to adults, and the lack of clinical phase-III trials to assess the efficacy of antifungal agents in the paediatric populations
Summary
The European Paediatric Mycology Network (EPMyN) was launched in 2014 to create a European platform for research and education in the field of paediatric mycology. The detailed objectives of the EPMyN are threefold: (1) to investigate the clinical epidemiology of invasive fungal infections in neonates and children, (2) to investigate new diagnostic and treatment modalities of fungal infections in specific paediatric groups, and (3) to create a forum for educating and training colleagues in the field of paediatric mycology. The need for EPMyNcan be found in the unique epidemiology of invasive fungal infections in neonates and children, differences in pharmacokinetics of antifungal agents and usefulness of fungal diagnostic measures compared to adults, and the lack of clinical phase-III trials to assess the efficacy of antifungal agents in the paediatric populations. Developing and executing cross-Atlantic clinical research, taking into account the differences in regulatory, data safety and legal issues between the USA and Europe will enhance future collaborative activities aimed at a better understanding and improved outcome of invasive fungal infections in neonates and children
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
